Jump Financial, LLC Madrigal Pharmaceuticals, Inc. Transaction History

Jump Financial, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 21, 2024	BUY	$146.04 - $225.78 $126,762 - $195,977	868 Added 58.22%	2,359 $344,000
Q3 2023 Nov 07, 2023	BUY	$146.04 - $225.78 $126,762 - $195,977	868 Added 58.22%	2,359 $344,000
Q2 2023 Oct 21, 2024	SELL	$203.88 - $312.0 $3.94 Million - $6.02 Million	-19,304 Reduced 92.83%	1,491 $344,000
Q2 2023 Aug 07, 2023	SELL	$203.88 - $312.0 $3.94 Million - $6.02 Million	-19,304 Reduced 92.83%	1,491 $344,000
Q1 2023 Oct 21, 2024	BUY	$231.06 - $307.08 $4.8 Million - $6.39 Million	20,795 New	20,795 $5.04 Million
Q1 2023 May 03, 2023	BUY	$231.06 - $307.08 $3.74 Million - $4.98 Million	16,207 Added 353.25%	20,795 $5.04 Million
Q4 2022 Feb 13, 2023	BUY	$58.39 - $296.54 $267,893 - $1.36 Million	4,588 New	4,588 $1.33 Million

297

21.9M

757K

370K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $3.72B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.